Duloxetine: a review of its pharmacology and use in chronic pain management.

作者: Geoff A. Bellingham , Philip W.H. Peng

DOI: 10.1097/AAP.0B013E3181DF2645

关键词: Pain ladderAnesthesiaNorepinephrine reuptake inhibitorAntidepressantDuloxetineMedicineChronic painFibromyalgiaMajor depressive disorderAnalgesic

摘要: Duloxetine is a serotonin and norepinephrine reuptake inhibitor that possesses antidepressant pain-relieving properties. Compared with other antidepressants, it has high affinity for both transporters, which are relatively balanced. Analgesic onset been observed within the first week of administration in randomized controlled trials likely obtained by enhancing tone descending pain inhibition pathways central nervous system. Randomized have documented significant analgesic effects managing chronic associated fibromyalgia diabetic peripheral neuropathic pain. Studies also suggested major depressive disorder can be reduced this medication. Modest headache, osteoarthritic pain, secondary to Parkinson disease documented, but data from single-blinded or open-label require further corroboration larger studies. not yet directly compared antidepressants anticonvulsants treatment syndromes.

参考文章(76)
Ruth Djaldetti, Eldad Melamed, Ron Dabby, Shlomit Yust-Katz, Vadim Kolianov, The effect of duloxetine on primary pain symptoms in Parkinson disease. Clinical Neuropharmacology. ,vol. 30, pp. 201- 205 ,(2007) , 10.1097/WNF.0B013E3180340319
Joachim Wernicke, Alberto Lled??, Joel Raskin, Daniel K Kajdasz, Fujun Wang, An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies Drug Safety. ,vol. 30, pp. 437- 455 ,(2007) , 10.2165/00002018-200730050-00007
Michael J Detke, Charles B Nemeroff, Alan F Schatzberg, Yili Lu, Pierre V Tran, David J Goldstein, Craig Mallinckrodt, Duloxetine for the treatment of major depressive disorder. Psychopharmacology Bulletin. ,vol. 36, pp. 106- 132 ,(2002)
A T Masi, J C Aldag, M B Yunus, P C Jobe, J W Dailey, Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study The Journal of Rheumatology. ,vol. 19, pp. 90- 94 ,(1992)
Joel E Michalek, Martin A Javors, E. M. Fletcher, G. A. Vipraio, C. A. Bowden, I. J. Russell, Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. The Journal of Rheumatology. ,vol. 19, pp. 104- 109 ,(1992)
K Kasamo, C De Montigny, P Blier, Blockade of the serotonin and norepinephrine uptake processes by duloxetine: in vitro and in vivo studies in the rat brain. Journal of Pharmacology and Experimental Therapeutics. ,vol. 277, pp. 278- 286 ,(1996)
Michael E. Thase, Pierre V. Tran, Curtis Wiltse, Beth A. Pangallo, Craig Mallinckrodt, Michael J. Detke, Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine. Journal of Clinical Psychopharmacology. ,vol. 25, pp. 132- 140 ,(2005) , 10.1097/01.JCP.0000155815.44338.95
S.K. Joshi, G. Hernandez, J.P. Mikusa, C.Z. Zhu, C. Zhong, A. Salyers, C.T. Wismer, P. Chandran, M.W. Decker, P. Honore, Comparison of antinociceptive actions of standard analgesics in attenuating capsaicin and nerve-injury-induced mechanical hypersensitivity Neuroscience. ,vol. 143, pp. 587- 596 ,(2006) , 10.1016/J.NEUROSCIENCE.2006.08.005
Frank Porreca, Michael H Ossipov, GF Gebhart, Chronic pain and medullary descending facilitation Trends in Neurosciences. ,vol. 25, pp. 319- 325 ,(2002) , 10.1016/S0166-2236(02)02157-4